It has been reported earlier that the expressions of pro-inflammatory cytokines, mainly IL-1β, IL-6, and TNF-α, in the intestinal mucosa of IBD patients were found to be markedly enhanced [24]. The gene discussed is IL1B; the disease is inflammatory bowel disease.